Publications by authors named "Kaela Porter"

Claim this Profile
A
A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Escalation Study to Evaluate the Safety and Pharmacokinetics of ELX-02 in Healthy Subjects.
Andi Leubitz, Frederic Vanhoutte, Ming-Yi Hu, Kaela Porter, Efrat Gordon

Clin Pharmacol Drug Dev· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1 Renal Impairment Trial Results Supports Targeted Individualized Dosing of ELX-02 in Patients With Nephropathic Cystinosis.
Thomas Haverty, David J Wyatt, Kaela M Porter, Andi Leubitz, Kate Banks

J Clin Pharmacol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An amphipathic peptide with antibiotic activity against multidrug-resistant Gram-negative bacteria.
Alysha G Elliott, Johnny X Huang, Søren Neve, Johannes Zuegg, Ingrid A Edwards, Kaela M Porter

Nat Commun· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis